ctrl K

AbCellera Biologics Inc. (ABCL)

NASDAQ: ABCL · Real-Time Price · USD

2.50

-0.11 (-4.21%)

At close: May 01, 2025, 3:59 PM

2.48

-0.61%

After-hours: May 01, 2025, 06:19 PM EDT

AbCellera Biologics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	28.83M	38.02M	485.42M	375.2M	233.16M	11.61M	8.83M
Cost of Revenue	97M	n/a	66.44M	45.52M	27.14M	10.11M	5.8M
Gross Profit	-68.17M	38.02M	418.99M	329.69M	206.01M	1.5M	3.03M
Operating Income	-314.77M	-237.21M	216.51M	204.41M	156.03M	-4.12M	-753K
Interest Income	38.47M	42.25M	16.08M	3.33M	293K	154.96K	42K
Pretax Income	-200.4M	-174.03M	239.1M	219.15M	157.83M	-2.21M	309K
Net Income	-162.86M	-146.4M	158.52M	153.46M	118.92M	-2.42M	309K
Selling & General & Admin	85.49M	75.18M	66.75M	48.76M	15.75M	4.01M	2.86M
Research & Development	167.26M	175.66M	107.88M	62.06M	29.39M	10.11M	5.8M
Other Expenses	90.85M	24.39M	17.29M	-3.04M	-3.48M	-170.41K	-675.51K
Operating Expenses	343.6M	275.23M	191.92M	107.79M	41.66M	13.95M	7.99M
Interest Expense	n/a	n/a	4.04M	5.22M	6.51M	209.2K	212K
Selling & Marketing Expenses	12.78M	14.18M	11.27M	6.91M	3.84M	1.26M	712K
Cost & Expenses	343.6M	275.23M	258.36M	153.3M	68.8M	13.95M	7.99M
Income Tax Expense	-37.54M	-27.63M	80.58M	65.69M	38.91M	209.2K	1.27M
Shares Outstanding (Basic)	294.33M	289.17M	285.06M	275.76M	269.5M	154.09M	237.72M
Shares Outstanding (Diluted)	294.33M	289.17M	314.83M	318.29M	269.5M	154.09M	237.72M
EPS (Basic)	-0.55	-0.51	0.56	0.56	0.44	-0.02	0.00
EPS (Diluted)	-0.55	-0.51	0.50	0.48	0.44	-0.02	0.00
EBITDA	-204.15M	-192.16M	272.2M	241.62M	169.62M	-397.42K	165K
EBIT	-301.15M	-223.05M	227.06M	204.41M	156.03M	-2M	521K
Depreciation & Amortization	97M	30.89M	33.1M	17.25M	5.27M	1.6M	918.46K